9h
Zacks.com on MSNPfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3BPfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...
10h
Pharmaceutical Technology on MSNPfizer sells 7.3% stake in Haleon for $3.3bnThe disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.
A major employer in Dungarvan has seen Pfizer, its single largest shareholder, sell its entire stake in the company for ...
NeuroSense's Groundbreaking ALS Combination Therapy PrimeC Advances Towards commercialization in Canada; Potential for revenue in Canada alone of $100-150 million dollars. PrimeC Has Previously ...
GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...
The FDA has started a priority review of GSK's gepotidacin, which could become the first in a new class of oral antibiotics for uncomplicated urinary tract infections (uUTIs) in over 20 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results